
News
from the fight to #SaveIndiePharmacy
New York Times’ The Middlemen series

Congress must take on Pharmacy Benefit Manager Reform. It's a bipartisan win | Opinion
The U.S. is increasingly politically polarized, with few issues where voters and elected officials on both sides of the aisle find common ground. But over the past year, one issue has brought everyone together: a distrust of pharmacy benefit managers (PBMs).

Lawmakers Plot to Force Health Insurers to Sell Off Pharmacies
Bipartisan bills would make healthcare companies with pharmacy-benefit managers divest their pharmacies

The Opaque Industry Secretly Inflating Prices for Prescription Drugs
Pharmacy Benefit Managers (PBMs) are driving up drug costs for millions of people, employers and the government.
The second in “THE MIDDLEMEN” series of articles by reporters Rebecca Robins and Reed Abelson investigating PBMs.
Drugmakers including Purdue Pharma paid pharmacy benefit managers not to restrict painkiller prescriptions, a New York Times investigation found.